Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults

Completed

Conditions studied: HIV Infections

In brief

Oral human papillomavirus (HPV) and oral warts are common health concerns for HIV-infected people. This study will examine the frequency of oral HPV DNA shedding and oral warts in HIV-infected people who are enrolled in ACTG A5257 and who are beginning treatment with highly active antiretroviral therapy (HAART).

Key facts

Study ID

NCT01029249

Run by

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

People needed

500

Starts

2010-01-01

Expected to finish

2013-05-01

Last updated by the study team

2013-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet inclusion criteria for and be enrolled in ACTG A5257
• Ability and willingness of participant or legal guardian/representative to provide informed consent

You may not qualify if…

• Co-enrollment in A5260s
• Has begun receiving HAART as part of the A5257 study
• Has ever received an HPV vaccine or plans to receive an HPV vaccine in the 6 months after study entry

Where it is running

• Alabama Therapeutics CRS (5801) — Birmingham, Alabama, United States
• University of Southern California CRS (1201) — Los Angeles, California, United States
• UCLA CARE Center CRS (601) — Los Angeles, California, United States
• Stanford — Palo Alto, California, United States
• Ucsd, Avrc Crs (701) — San Diego, California, United States
• University of California San Francisco AIDS CRS (801) — San Francisco, California, United States
• University of Miami AIDS CRS (901) — Miami, Florida, United States
• The Ponce de Leon Ctr. CRS (5802) — Atlanta, Georgia, United States
• Northwestern University CRS (2701) — Chicago, Illinois, United States
• Rush University Medical Center (2702) — Chicago, Illinois, United States
• IHV Baltimore Treatment CRS (4651) — Baltimore, Maryland, United States
• Beth Israel Deaconess Medical Center ACTG CRS (103) — Boston, Maryland, United States
• Massachusetts General Hospital ACTG CRS (101) — Boston, Massachusetts, United States
• Henry Ford Hosp. CRS (31472) — Detroit, Michigan, United States
• Washington University CRS (2101) — St Louis, Missouri, United States
• Cooper Univ. Hosp. CRS (31476) — Camden, New Jersey, United States
• New Jersey Medical School- Adult Clinical Research Ctr. CRS — Newark, New Jersey, United States
• Cornell CRS (7804) — New York, New York, United States
• HIV Prevention and Treatment — New York, New York, United States
• AIDS Care CRS (1108) — Rochester, New York, United States
• University of Rochester ACTG CRS (1101) — Rochester, New York, United States
• University of North Carolina AIDS CRS — Chapel Hill, North Carolina, United States
• Duke Univ. Med. Ctr. Adult CRS (1601) — Durham, North Carolina, United States
• Moses H. Cone Memorial Hosp. CRS — Greensboro, North Carolina, United States
• University of Cincinnati CRS — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.